Eylon 0.1%+0.025% (Ophthalmic Solution)

Indications

• Acute and chronic allergic non-infectious conjunctivitis and keratitis with severe swelling and intravascular injection
• Non-infectious inflammation of the anterior segment of the eye
• Post-operative irritative conditions after strabismus
• Cataract surgery with supplementary antimicrobial therapy

Pharmacology

• Fluorometholone induces phospholipase A2 inhibitory proteins
• Tetrahydrozoline is an alpha agonist
• Constricts conjunctival blood vessels

Dosage & Administration

• 1 drop into the conjunctival sac 2-3 times daily for adults
• Increased dose for severe cases to 1 drop hourly for first one to two days

Interaction

• Possible interaction with antidepressant drugs inhibiting MAO Enzyme

Contraindications

• Infectious conjunctivitis or keratitis
• Glaucoma
• Dry eyes

Side Effects

• Mild burning sensation
• Reversible increase in intraocular pressure
• Reactive hyperemia
• Cataract & corneal defects
• Glaucoma
• Systemic effects (chronic use)

Pregnancy & Lactation

• Use during pregnancy only if potential benefits justify the potential risk to the fetus

Precautions & Warnings

• Avoid prolonged use
• Risk benefit evaluation in severe blood circulation diseases
• Metabolic disturbances
• Under treatment with MAOIs
• History of cataract
• Herpes simplex infection
• Rhinitis sicca

Overdose Effects

• No likelihood of overdose when used as directed
• Possible symptoms of intoxication
• Administration of activated charcoal
• Gastric lavage
• Artificial ventilation with oxygen
• Use of phentolamine to lower blood pressure
• Antipyretic and anticonvulsive therapy

Therapeutic Class

• Ophthalmic Steroid preparations

Storage Conditions

• Keep out of the reach of children
• Store in a cool, dry place
• Do not use more than 4 weeks after opening

Related Brands

• AFM-T 0.1%+0.025% (Ophthalmic Solution) - aristopharma-ltd
• Refemoline 0.1%+0.025% (Ophthalmic Solution) - reman-drug-laboratories-ltd